ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.

Ryan T Muir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.